Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Memantine Augmentation of Targeted Cognitive Training in Schizophrenia

NCT04857983 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT04857983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04857983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Memantine Augmentation of Targeted Cognitive Training in Schizophrenia
Lead sponsor
University of California, San Diego
Phase
Phase 2/3
Overall status
Completed
Start date
July 6, 2021
Completion date
March 30, 2025
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia